Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

New challenges in treatment of elderly CLL patients

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.11.15
Views: 2158

Prof Barbara Eichhorst- Center for Integrated Oncology, Cologne, Germany

Prof Eichhorst talks to ecancertv at SIOG 2015 about new challenges in treatment of elderly chronic lymphocytic leukaemia (CLL) patients. 

Combinations of chemotherapy and antibodies are becoming standard in younger and/or physically fit patients.

Concomitant diseases and physically fitness are playing a major role for the selection of treatment for elderly patients.

So far, there is no ideal tool to measure the comborbidity burden, but a geriatric assessment before treatment initiation is strongly recommended.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation